The Pharma LCA Consortium, supported by its technical advisor Quantis, has developed a technical guidance document to accompany PAS 2090. This guidance aims to facilitate implementation by providing practical recommendations and illustrative examples. Version 1.1 has been issued to address identified discrepancies with PAS 2090, notably in relation to table referencing, and to improve overall clarity and alignment.
A joint publication by the International Federation of Pharmaceutical Wholesalers and the Pharmaceutical Environment Group to align on GHG reporting and data sharing approaches between pharmaceutical companies and wholesalers.
This FAQ document is tailored for pharmaceutical suppliers and addresses common questions about PAS 2090, Life Cycle Assessments, available datasets and tools, and other practical considerations for implementation.
This abstract describes the initial steps in an overarching programme to improve the measurement and reporting of environmental information for medicines. The technical work described is a key foundational element that will lead to the development of a universal, consensus-led standard for the benefit of the global healthcare systems, in its many forms, and ultimately for the improved health of patients and the environment in which they live.